Nortriptyline Milpharm (Nortriptyline)

Nortriptyline blocks the reuptake of norepinephrine and serotonin, increasing their availability at synaptic sites. It also antagonizes muscarinic, histamine H1, and alpha‑adrenergic receptors, which contributes to its therapeutic effects on mood and pain, as well as to its characteristic side‑effect profile.

The appropriate dose of nortriptyline is individualized by the prescribing clinician based on the patient’s condition, age, renal and hepatic function, and response to therapy. Dosage adjustments are made during treatment to achieve optimal clinical benefit while minimizing adverse effects.

Safety data for nortriptyline in pregnancy and lactation are limited. It should only be used if the potential benefit justifies the potential risk to the fetus or infant. Healthcare providers should discuss possible risks and consider alternative therapies when appropriate.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Nortriptyline belongs to the tricyclic antidepressant class, which differs from selective serotonin reuptake inhibitors (SSRIs) and serotonin‑norepinephrine reuptake inhibitors (SNRIs) in its broader receptor profile. It may be more effective for certain pain conditions but typically has a higher incidence of anticholinergic side effects, requiring careful patient selection.

Nortriptyline Milpharm tablets should be stored at temperatures below 25 °C, in the original container, protected from moisture and direct sunlight. Keep the product out of reach of children and do not use after the expiry date printed on the label.

The medication is taken orally, usually once daily in the evening to reduce daytime sedation. Tablets should be swallowed whole with a full glass of water and may be taken with or without food, as directed by the prescribing clinician.

Serious risks include cardiac arrhythmias, especially in patients with pre‑existing heart disease, seizures at high plasma concentrations, severe hypotension, agranulocytosis, and the potential for serotonin syndrome when combined with other serotonergic agents. Prompt medical attention is required if any of these events occur.

Nortriptyline is contraindicated in individuals with a known hypersensitivity to the drug, recent use of monoamine oxidase inhibitors, or those with uncontrolled narrow‑angle glaucoma. Caution is also advised for patients with severe cardiac conduction disorders, recent myocardial infarction, or a history of seizures.